Blood Flow Restriction Training (BFRT) science and research studies continue to abound due to the significant positive results of safe and effective Blood Flow Restriction Training on all populations as a way of developing strength, muscle, and promoting lean body mass.
A recent study published in Trends in Endocrinology and Metabolism, highlights Blood Flow Restriction Training and its potential application in Type 2 Diabetes, as well as the potential application and results in reducing or reversing sarcopenia - loss of skeletal muscle and function.
Blood flow restriction resistance training with patented B Strong BFR bands can induce gains in skeletal muscle mass and strength similar to those seen with traditional resistance training, with significantly lower loaded training -- resistance training with less weight.
The study found when comparing BFR with traditional high-load resistance training, "BFRT induces similar gains in muscle mass and strength. BFRT is thus an effective training strategy for people with physical limitations. Recent research indicates that BFRT has beneficial effects on glucose and mitochondrial metabolism. BFRT may therefore qualify as a valuable exercise alternative for individuals with type 2 diabetes (T2D), a disorder characterized by impaired glucose metabolism, musculoskeletal decline, and exacerbated progression of sarcopenia. This review covers the effects of BFRT in healthy populations and in persons with impaired physical fitness, the mechanisms of action of this novel training modality, and possible applications for individuals with T2D." In addition to impaired glucose metabolism and physical fitness, individuals with type 2 diabetes are at increased risk of sarcopenia. For these individuals, low-load Blood Flow Restriction Training or BFRT may be an effective exercise modality."
SOURCES
Effects of Blood Flow Restriction Exercise and Possible Applications in Type 2 Diabetes - PubMed
Effects of Blood Flow Restriction Exercise and Possible Applications in Type 2 Diabetes - CellPress
